As of 2026-05-18, the EV/EBITDA ratio of Microbix Biosystems Inc (MBX.TO) is -16.89. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MBX.TO's latest enterprise value is 28.82 mil CAD. MBX.TO's TTM EBITDA according to its financial statements is -1.71 mil CAD. Dividing these 2 quantities gives us the above MBX.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.6x - 14.4x | 12.0x |
| Forward P/E multiples | 7.3x - 10.9x | 9.1x |
| Fair Price | (0.10) - (0.12) | (0.11) |
| Upside | -145.6% - -152.8% | -150.8% |
| Date | EV/EBITDA |
| 2026-05-15 | -16.89 |
| 2026-05-14 | -17.29 |
| 2026-05-13 | -19.32 |
| 2026-05-12 | -20.13 |
| 2026-05-11 | -18.91 |
| 2026-05-08 | -18.91 |
| 2026-05-07 | -18.91 |
| 2026-05-06 | -18.51 |
| 2026-05-05 | -18.91 |
| 2026-05-04 | -19.32 |
| 2026-05-01 | -19.32 |
| 2026-04-30 | -19.32 |
| 2026-04-29 | -18.91 |
| 2026-04-28 | -18.91 |
| 2026-04-27 | -19.72 |
| 2026-04-24 | -18.51 |
| 2026-04-23 | -18.51 |
| 2026-04-22 | -18.91 |
| 2026-04-21 | -18.51 |
| 2026-04-20 | -18.10 |
| 2026-04-17 | -18.10 |
| 2026-04-16 | -18.10 |
| 2026-04-15 | -18.51 |
| 2026-04-14 | -18.51 |
| 2026-04-13 | -18.10 |
| 2026-04-10 | -18.10 |
| 2026-04-08 | -18.10 |
| 2026-04-07 | -16.89 |
| 2026-04-06 | -18.51 |
| 2026-04-02 | -16.89 |
| 2026-04-01 | -17.70 |
| 2026-03-30 | -16.89 |
| 2026-03-27 | -17.29 |
| 2026-03-26 | -17.70 |
| 2026-03-25 | -18.10 |
| 2026-03-24 | -17.29 |
| 2026-03-23 | -18.10 |
| 2026-03-20 | -18.91 |
| 2026-03-19 | -18.91 |
| 2026-03-18 | -18.91 |
| 2026-03-17 | -18.51 |
| 2026-03-16 | -18.91 |
| 2026-03-13 | -18.10 |
| 2026-03-12 | -18.91 |
| 2026-03-11 | -19.72 |
| 2026-03-10 | -19.72 |
| 2026-03-09 | -17.29 |
| 2026-03-06 | -17.29 |
| 2026-03-05 | -17.29 |
| 2026-03-04 | -17.70 |